Literature DB >> 10989609

Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin.

S Di Nuzzo1, R M Sylva-Steenland, C W Koomen, M A de Rie, P K Das, J D Bos, M B Teunissen.   

Abstract

Normal human skin shows preferential (epi)dermal infiltration of CD4+ T cells upon acute UV exposure. To study the mechanism behind this feature we locally exposed healthy volunteers to doses of UV commonly encountered by the population. Expression of integrins on T cells and expression of adhesion molecules on dermal endothelial cells were quantitatively assessed by immunohistochemistry in situ. We also investigated the effects of ultraviolet-B (UVB) exposure on psoriasin and IL-16, two specific chemoattractant factors for CD4+ T cells, at messenger RNA (mRNA) level by semiquantitative reverse transcriptase-polymerase chain reaction and at protein level by immunohistochemistry. We found, at day 2 after exposure to four minimal erythema doses of UVB, predominant accumulation of LFA-1+/CLA-/VLA-4- T cells in the dermis. Concomitantly the expression of ICAM-1, but not that of E-selectin and VCAM-1, was upregulated on dermal endothelial cells. The increase in the number of dermal T cells was not due to proliferation because only 2% of the UVB-induced dermal T cells expressed the marker of proliferation Ki-67. Whereas exposure to 35 J/cm2 of ultraviolet-A (UVA), like UVB, induced a loss of intraepidermal T cells at day 2 after exposure, UVA induced neither any influx of T cells into the dermis nor any adhesion molecule upregulation on endothelial cells. In response to UVB exposure, the expression of psoriasin mRNA, but not of IL-16 mRNA, was upregulated; the expression of psoriasin protein was also found to be upregulated. These results suggest that LFA-1/ICAM-1 pathway and psoriasin are both involved in the accumulation of CD4+ T cells into UVB-irradiated skin, possibly via a recruitment mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989609     DOI: 10.1562/0031-8655(2000)072<0374:etuiao>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  6 in total

1.  S100 protein subcellular localization during epidermal differentiation and psoriasis.

Authors:  Ann-Marie Broome; David Ryan; Richard L Eckert
Journal:  J Histochem Cytochem       Date:  2003-05       Impact factor: 2.479

2.  S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.

Authors:  K K Dey; R Bharti; G Dey; I Pal; Y Rajesh; S Chavan; S Das; C K Das; B C Jena; P Halder; J G Ray; I Kulavi; M Mandal
Journal:  Cancer Gene Ther       Date:  2016-10-21       Impact factor: 5.987

3.  Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.

Authors:  Noemi Moubayed; Michael Weichenthal; Jürgen Harder; Elke Wandel; Michael Sticherling; Regine Gläser
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-29       Impact factor: 4.553

4.  Psoriasin (S100A7) expression is altered during skin tumorigenesis.

Authors:  Salem Alowami; Gefei Qing; Ethan Emberley; Linda Snell; Peter H Watson
Journal:  BMC Dermatol       Date:  2003-02-24

5.  Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.

Authors:  Ronald Wolf; O M Zack Howard; Hui-Fang Dong; Christopher Voscopoulos; Karen Boeshans; Jason Winston; Rao Divi; Michele Gunsior; Paul Goldsmith; Bijan Ahvazi; Triantafyllos Chavakis; Joost J Oppenheim; Stuart H Yuspa
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

6.  Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.

Authors:  Kaushik Kumar Dey; Siddik Sarkar; Ipsita Pal; Subhasis Das; Goutam Dey; Rashmi Bharti; Payel Banik; Joygopal Roy; Sukumar Maity; Indranil Kulavi; Mahitosh Mandal
Journal:  Cancer Cell Int       Date:  2015-07-29       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.